SmPC - Cytarabine Accord 20 mg/ml solution for injection/infusion: Change history
View Summary of Product Characteristics (SmPC - Cytarabine Accord 20 mg/ml solution for injection/infusion)
Last updated on this site: 04 Feb 2025
To register updated sections 4.2, 4.3 ,4.4, 4.5, 4.6 and 4.8 of the SmPC fragments. This is in line with the information of Reference product (Cytarabine 20 mg/ml Solution for Injection or Infusion; National authorisation number: PA0822/200/001; MAH: Pfizer Healthcare Ireland). Consequently, the leaflet is updated.
View Summary of Product Characteristics (SmPC - Cytarabine Accord 20 mg/ml solution for injection/infusion)
Last updated on this site: 04 Feb 2025
To register updated sections 4.2, 4.3 ,4.4, 4.5, 4.6 and 4.8 of the SmPC fragments. This is in line with the information of Reference product (Cytarabine 20 mg/ml Solution for Injection or Infusion; National authorisation number: PA0822/200/001; MAH: Pfizer Healthcare Ireland). Consequently, the leaflet is updated.
-
Changes: (Updated: 04 Feb 2025)
To register updated sections 4.2, 4.3 ,4.4, 4.5, 4.6 and 4.8 of the SmPC fragments. This is in line with the information of Reference product (Cytarabine 20 mg/ml Solution for Injection or Infusion; National authorisation number: PA0822/200/001; MAH: Pfizer Healthcare Ireland). Consequently, the leaflet is updated.
-
Changes: (Updated: 08 Aug 2023)
Renewal approval 02/08/2023
-
Changes: (Updated: 21 Oct 2022)
Update
-
Changes: (Updated: 20 Sep 2022)
Initial upload